These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 10686314)
21. Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients--a single center experience. El-Sabrout R; Delaney V; Qadir M; Butt F; Hanson P; Butt KM Transplant Proc; 2003 May; 35(3 Suppl):89S-94S. PubMed ID: 12742474 [No Abstract] [Full Text] [Related]
22. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. Forsythe J Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049 [No Abstract] [Full Text] [Related]
23. A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus. Daoud AJ; Schroeder TJ; Shah M; Hariharan S; Peddi VR; Weiskittel P; First MR Transplant Proc; 1998 Dec; 30(8):4079-81. PubMed ID: 9865303 [No Abstract] [Full Text] [Related]
24. Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine. Spagnoletti G; Citterio F; Favi E; Rossi E; Delreno F; De Santis I; Salerno MP; Gargiulo A; Castagneto M Transplant Proc; 2009 May; 41(4):1175-7. PubMed ID: 19460509 [TBL] [Abstract][Full Text] [Related]
25. Clinical study of FK 506 in renal transplant recipients. Youhua Z; Zhinlian M; Liming W Transplant Proc; 2000 Nov; 32(7):1704. PubMed ID: 11119900 [No Abstract] [Full Text] [Related]
31. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. Pascual J; van Hooff JP; Salmela K; Lang P; Rigotti P; Budde K Transplantation; 2006 Jul; 82(1):55-61. PubMed ID: 16861942 [TBL] [Abstract][Full Text] [Related]
33. Progress with cyclosporine-sparing regimens. Grinyó JM Transplant Proc; 1999 Dec; 31(8A):11S-16S. PubMed ID: 10616555 [No Abstract] [Full Text] [Related]
34. Sirolimus antirejection therapy for renal transplantation with cyclosporine-based immunosuppression: case reports. Tsai MK; Hu RH; Lee PH Transplant Proc; 2003 Feb; 35(1):219-20. PubMed ID: 12591371 [No Abstract] [Full Text] [Related]
35. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S; Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205 [TBL] [Abstract][Full Text] [Related]
36. Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation. Weir MR Transplant Proc; 2001 Jun; 33(4 Suppl):19S-28S. PubMed ID: 11406264 [No Abstract] [Full Text] [Related]
37. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625 [No Abstract] [Full Text] [Related]
38. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989 [TBL] [Abstract][Full Text] [Related]